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Background: Alcohol consumption is steadily
increasing in high-income countries but the harm and
possible net benefits of light-to-moderate drinking
remain controversial. We prospectively investigated the
association between time-varying alcohol consumption
and overall and cause-specific mortality among middle-
aged women.
Methods: Among 48 249 women at baseline (33 404
at follow-up) in the prospective Swedish Women’s
Lifestyle and Health cohort, age 30–49 years at
baseline, we used repeated information on alcohol
consumption and combined this method with multiple
imputation in order to maximise the number of
participants and deaths included in the analyses.
Multivariable Cox regression models were used to
calculate HRs for overall and cause-specific mortality.
Results: During >900 000 person/years, a total of
2100 deaths were recorded through Swedish registries.
The median alcohol consumption increased from
2.3 g/day in 1991/1992 (baseline) to 4.7 g/day in
2004 (follow-up). Compared with light drinkers
(0.1–1.5 g/day), a null association was observed for all
categories of alcohol consumption with the exception
of never drinkers. The HR comparing never with light
drinkers was 1.46 (95% CI 1.22 to 1.74). There was a
statistically significant negative trend between
increasing alcohol consumption and cardiovascular
and ischaemic heart diseases mortality. The results
were similar when women with prevalent conditions
were excluded.
Conclusions: In conclusion, in a cohort of young
women, light alcohol consumption was protective for
cardiovascular and ischaemic heart disease mortality
but not for cancer and overall mortality.
INTRODUCTION
According to the WHO, alcohol consumption
is steadily increasing in high-income countries
and causally related to upper aerodigestive
tract (UADT), liver, colorectal and female
breast cancer.1 Worldwide, in 2012, 4% of all
global female deaths were attributable to
alcohol consumption. Alcohol-attributable
deaths are highest in the European Region
and particularly in high-income countries
within Europe.2 In two recent studies, heavy
alcohol consumption increased mortality from
alcohol-related cancer (ARC), external causes
and ‘other causes’ (external causes of
deaths),3 4 while no association was observed
for coronary heart disease (CHD) and other
cardiovascular diseases (CVDs).3 A J-shaped
association between alcohol and all-cause mor-
tality was been observed in two recent
meta-analyses of prospective studies.5 6
Moderate alcohol drinking has been asso-
ciated with a reduction in cardiovascular mor-
tality7 but this is not consistent among studies.
A recent meta-analysis found that low-volume
alcohol consumption has no net mortality
benefit compared with lifetime abstention or
occasional drinking.8 Some investigators argue
that this proposed benefit depends on the
Strengths and limitations of this study
▪ This study was based on information on dietary
and lifestyle exposure collected in the Swedish
Women’s Lifestyle and Health prospective cohort
study of young and middle-aged women.
▪ We used repeated information on alcohol con-
sumption and combined this method with mul-
tiple imputation in order to maximise the
number of participants and deaths included in
the analyses.
▪ Analyses excluding participants with morbid con-
dition at cohort entry, and isolating women who
stopped drinking between baseline and follow-up
minimised reverse causality bias in our study.
▪ Main limitations included the small number of
cases for specific causes of death among
women drinking ≥15 g/day and that we had no
information on excessive alcohol consumption in
the Swedish Women’s Lifestyle and Health
cohort study.
▪ Although statistical models included many
potentially relevant adjustment factors, residual
confounding might partially account for the
observed associations.
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choice of reference group.9 Studies on light-to-moderate
alcohol consumption over time and risk of death in
women are, however, scarce.10 Within the Swedish
Women’s Lifestyle and Health (WLH) Study, an earlier
analysis showed that a possible beneficial effect of
light-to-moderate alcohol drinking was limited to CVD/
CHD mortality, with no measurable increase in overall
cancer mortality.11 In the current study, we quantify the
associations between time-varying alcohol consumption
and overall and cause-specific mortality, including cancer
mortality—separating ARC and other cancers—death
from CVDs, violence and injuries and other causes.
METHODS
Study population
The WLH cohort is a prospective study of women
recruited between August 1991 and June 1992 in the
Uppsala Healthcare Region, Sweden when 96 000 female
residents aged 30–49 years were randomly selected and
mailed a self-report questionnaire. Of these, 49 259
(51%) women gave their informed consent and were
enrolled in the WLH study. A follow-up questionnaire,
mailed between February 2003 and January 2004 to all
cohort participants who were still alive, was completed
and returned by 34 402 women. Both the baseline
(1991/1992 questionnaire) and the follow-up question-
naire requested information regarding anthropometric
measurements, personal history of diseases, smoking and
drinking habits, diet and physical activity. The cohort
profile has been previously described in detail.12 We
excluded participants with implausible energy intake,
outside the 1st and 99th centiles, and those who emi-
grated without re-immigration before enrolment
(n=990). The final cohort comprised 48 249 women.
Measure of alcohol consumption
In the baseline questionnaire, each woman was asked:
‘How much alcohol do you drink per week, month or
year?’ for five different types of alcohol: class II
beer (1 glass=2 dL), class III beer (1 glass=2 dL), wine
(1 glass=1 dL), fortified wine (1 glass=4 cL) and spirits
(1 glass=4 cL). Response categories were open, and
included number of glasses per week, month and year,
respectively. Furthermore, it was possible to answer that
alcoholic beverages were consumed seldom or not at all.
In the follow-up questionnaire, each woman was asked if
she drank alcohol, and if the answer was affirmative, she
was asked ‘How often on average do you usually drink
the following kinds of alcohol?’ for seven different types
of alcohol: low alcohol beer, beer, white wine, red wine,
dessert wine and spirits. Apart from these questions, cor-
responding to the questions in the baseline question-
naire, each woman was asked about binge drinking and
if alcohol was usually consumed with meals. These ques-
tions were not included in this study. The follow-up
questionnaire contained similar corresponding questions
regarding alcohol intake. The reported glasses of
alcohol were converted to grams of alcohol using food
composition data from the Swedish National Food
Administration (http://www7.slv.se/SokNaringsinnehall/
Home/ToggleLanguage) for both the baseline and
follow-up questionnaires. This gives the grams of alcohol
per glass for the aforementioned different categories of
alcoholic beverages, and thus allows conversion of
number of glasses to grams of alcohol.
Follow-up and mortality
Cohort members were followed from August 1991
through 31 December 2012 by linking the cohort to the
national registers (Death Register, Cancer Register and
Emigration Register) through their individually unique
national registration number,12 13 making follow-up vir-
tually complete.14
All Swedish death certificates are issued by a physician
and the quality of these have been found to be high.15
Causes of death were classified according to the
International Classification of Diseases, 10th Revision,
codes (ICD-10 codes or corresponding). In this study,
the following seven causes of death were considered:
ARC as defined by the International Agency for Cancer
Research,16 (breast cancer C50; colorectal cancer C18–
C20; UADT (including cancer of the mouth, C01–C15,
larynx, C32, and excluding salivary gland, C08)), other
cancers (all cancer mortality excluding ARC mortality),
CVD mortality excluding ischaemic heart diseases mor-
tality N=177 including (chronic rheumatic heart diseases
I05–I09; hypertensive diseases I10–I15; pulmonary heart
disease and diseases of pulmonary circulation I26–I28;
other forms of heart disease I30–I52; cerebrovascular
diseases I60–I69; diseases of arteries, arterioles and capil-
laries I70–I79; diseases of veins, lymphatic vessels and
lymph nodes, not elsewhere classified I80–I89; other and
unspecified disorders of the circulatory I95–I99), ischae-
mic heart diseases (IHD) I20–I25 which were studied
separately, external causes of deaths directly or indirectly
related to alcohol consumption including traffic injuries,
poisoning, drowning and intentional self-harm (ICD-10
V01–99, W00–99, X00–99, Y00–36, Y85–87, and Y89) and
other deaths (overall mortality minus all other previously
defined cause of deaths ie, excluding mortality from
ARC, other cancer, CVD, IHD and external causes).
Statistical analysis
As proposed by Hu et al,17 we applied baseline informa-
tion until follow-up information became available, until
of death, or emigration, whichever occurred first.
Thereafter, follow-up information was applied until age
of death, emigration or the end of the study period,
whichever occurred first. We used Cox proportional
hazard regression models to calculate HRs with 95%
CIs comparing abstainers with five categories of alcohol
consumption (0.1–1.49 g/day (reference group),
1.5–4.9, 5–9.9, 10–14.9 and 15+ g/day). Age was used as
the underlying time variable in all Cox regression ana-
lyses. The Breslow method was adopted for handling
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ties. Departures from proportional hazards assumption
in the Cox models was tested through inclusion of an
interaction variable between categories of alcohol intake
and underlying time (age) (http://www.ats.ucla.edu/
stat/examples/asa/test_proportionality.htm).
We decided a priori to adjust for age at recruitment,
smoking status (never, former, current, nmissing=0) and
duration of smoking (continuous nmissing=0), body mass
index (BMI; ≤18.49, 18.5–24.9, 25–29.9, and, ≥30 kg/m2
nmissing=1813) and height (continuous nmissing=911), edu-
cation attainment (≤9, 10–12, 13–16, ≥17 years nmissing-
=944), physical activity score derived from self-assessment
scale of 1 through 5 and considering both working and
leisure time (low (1–2), middle (3) and high (4–5), total
energy intake not from alcohol consumption (continu-
ous, in kJ/day), number of children (0, 1–2, ≥3, nmissing-
=0), age at first birth (<20, 20–24, 25–29, and ≥30 years,
nmissing=6782), oral contraceptive (yes/no nmissing=96)
use and duration (<3, 4–7, ≥8, nmissing=96), menopausal
status and age at menopause (premenopausal, postme-
nopausal at <51 years of age, and postmenopausal at
≥51 years of age nmissing=1985), and history of breast
cancer in mother or sister (yes/no nmissing=0).
We have used follow-up information on smoking
exposure and BMI, in addition to alcohol consumption,
for both complete-case analyses and analyses performed
in multiple imputed data sets.
The test for trend across categories of alcohol
consumption was based on the median alcohol intake
(g/day) in each category. We tested for interaction
between alcohol consumption and smoking status, BMI
or physical activity levels. For overall mortality, we
estimated the HRs of different categories of alcohol
consumption in never-smokers. For overall mortality, the
effect of age was further investigated by stratifying
according to age at enrolment (before (<) or after (≥)
40 years of age) and age at exit (before (<) or after (≥)
60 years of age). To reduce the risk of reverse causality,
sensitivity analyses were run excluding women with
prevalent conditions at cohort entry (n=7316: cancer
n=2932, stroke n=138, heart attack n=98 and hyperten-
sion n=4514, with 366 women experiencing more than
one of the conditions).
In a complementary set of analyses, we started follow-
ing the women for mortality from 2004 instead of 1991/
1992. We classified them according to the change in
alcohol consumption between 1991/1992 and 2004. We
created seven mutually exclusive categories: stop drink-
ing; start drinking; continue as never consumer; main-
tain a low level of alcohol consumption (<5 g/day);
maintain a high level (≥5 g/day); increased alcohol con-
sumption (from <5 to ≥5 g/day); and decreased alcohol
consumption (from ≥5 to <5 g/day). We estimated the
HRs and their 95% CI between the ‘change’ variable
and overall and cause-specific mortality. None of the
cofactors were considered as time-varying but all models
were adjusted for alcohol consumption in 1991/1992.
For this analysis, models were adjusted for baseline
(1991/1992) or follow-up (2004) characteristics when
we had the information (ie, smoking, physical activity
and BMI).
Dropping out of the study and multiple imputation
The women who dropped out of the study at follow-up
(n=14 404 (29.8%)) have been described elsewhere.12
Briefly, compared with women who did not drop out,
the women who dropped out had lower education
(35.9% vs 27.1%), were more often abstainers (17.0% vs
12.2%) and reported lower levels of daily alcohol con-
sumption (1.9 g/day vs 2.4 g/day). In order to deal with
the dropouts of the study, we used multiple imputation
models,18 and compared the results with complete case
Cox regression analyses. Multiple imputation models
were used under the assumption of data missing at
random. To reduce sampling variability, we created 20
replicate data sets from the imputation simulation.19
Separate imputation models were created for overall
death and cause-specific death. We used the
Nelson-Aalen cumulative hazard estimator as a predictor
in all the imputation models.20 We separately imputed
information from women who died or emigrated before
the follow-up questionnaire (age at exit < age at
follow-up questionnaire: 1351 women of whom 715
died) and those who died or emigrated after follow-up
(age at exit ≥ age at follow-up: 46 898 women of whom
1385 died).
We repeated the imputation procedure after excluding
women with prevalent conditions at baseline (n=7316)
and ran the time-varying Cox models for overall and
cause-specific mortality. The estimates from 20 imputed
data sets were combined using Rubin’s rules in order to
obtain HRs and corresponding 95% CI.21 Finally, we
compared the complete-case analysis with the results of
Cox models after imputation.
All the analyses and the multiple imputations were
done in SAS-V.9.4/STATA-V.13.1 (SAS Institute, USA/
Stata Corp, USA).
RESULTS
During >900 000 person/years, in 48 249 women at base-
line (33 845 women at follow-up), a total of 2100 deaths
were recorded (table 1). The median alcohol consump-
tion increased from 2.3 g/day in 1991/1992 to 4.7 g/day
in 2004. Simultaneously, the proportion of abstainers
decreased from 13.6% to 10.3% (10.8% including women
who dropped out of the study at follow-up). On average,
between baseline and follow-up, the majority (89.6%) of
WLH women were drinking <10 g/day (table 1).
Comparing point estimates (mean and percentages),
abstainers had more children, were younger at the time of
first birth, and were more likely to have prevalent health
conditions at baseline (table 1). Women drinking more
than 15 g/day were more often current smokers, had a
longer history of smoking, were more often nulliparous,
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Table 1 Women’s characteristics by baseline levels of alcohol consumption, the Women’s Lifestyle and Health cohort, 1991–2012 (N=48 249, N2004=33 845)
















Missing at follow-up (%) 37.1 30.0 28.5 27.5 28.3 28.6 29.8
Mean (SD) age at baseline 40.2 (6.0) 40.1 (5.9) 40.1 (5.7) 40.8 (5.6) 41.4 (5.6) 41.7 (5.5) 40.8 (5.8)
All death (n) 369 515 641 398 116 61 2100
ARC mortality (n) 61 115 129 89 27 9 430
Other cancers mortality (n) 139 209 283 161 47 22 861
CVD mortality (n) 41 40 50 35 6 5 177
IHD mortality (n) 34 35 29 25 4 1 128
External causes of deaths (n) 27 38 58 37 14 9 183
Other deaths (n) 70 87 100 56 22 17 352
Smoking status at baseline (%)
Never 51.0 47.6 41.1 32.5 26.4 17.6 41.4
Former 29.7 33.3 38.8 43.2 43.4 44.1 37.3
Current 19.3 19.2 20.1 24.3 30.2 38.3 21.4
Smoking status at follow-up (%)
Never 51.6 48.0 41.5 32.9 26.6 16.2 41.5
Former 28.5 32.2 38.3 43.4 45.6 46.9 37.0
Current 19.9 19.8 20.2 23.7 27.8 37.0 21.4
Mean (SD) smoking duration in years at baseline 9.9 (11.9) 10.2 (11.5) 11.3 (11.5) 13.7 (11.8) 16.1 (12.2) 19.1 (11.8) 11.7 (11.8)
Menopause status and age at menopause (%)
Premenopausal 89.6 91.2 92.0 91.4 91.0 90.8 91.3
Postmenopausal at <51 years of age 3.5 3.4 3.1 3.0 3.4 3.0 3.2
Postmenopausal at ≥51 years of age 1.8 1.3 1.2 1.5 1.5 1.3 1.4
Unknown 5.1 4.1 3.7 4.1 4.1 4.9 4.1
Mean (SD) baseline educational attainment (years) 11.4 (3.0) 12.0 (3.0) 12.3 (2.9) 12.7 (3.1) 12.8 (3.2) 12.9 (3.3) 12.2 (3.0)
Mean (SD) BMI (kg/m2) at baseline 24.2 (4.3) 23.7 (3.9) 24.2 (4.3) 23.3 (3.4) 23.1 (3.3) 23.1 (3.6) 23.5 (3.7)
Mean (SD) BMI (kg/m2) at follow-up 26.1 (4.9) 25.7 (4.5) 25.1 (4.0) 24.9 (3.9) 24.9 (4.1) 25.2 (4.2) 25.3 (4.3)
Mean (SD) physical activity score at baseline (5 categories) 3.0 (0.9) 3.1 (0.9) 3.2 (0.9) 3.2 (0.9) 3.2 (0.9) 3.0 (0.9) 3.0 (0.9)
Number of children (%)
None 15.6 12.4 12.9 15.2 19.5 22.1 14.1
1–2 51.51 58.16 60.93 60.3 57.86 54.48 58.55
3+ 32.9 29.43 26.15 24.56 22.65 23.4 27.4
Mean (SD) age at first birth (years) 23.6 (4.5) 24.2 (4.4) 24.3 (4.4) 24.5 (4.6) 23.4 (4.6) 24.3 (4.8) 24.2 (4.6)
Ever use of OC (%) 72.7 80.6 86.5 88.0 88.9 90.1 83.6
Mean (SD) duration of OC use (years) 6.0 (5.2) 6.4 (5.2) 6.8 (5.3) 7.1 (5.5) 7.3 (5.6) 7.6 (5.7) 6.7 (5.3)
Mean (SD) energy except from alcoholic beverages (kJ/day) 6315 (2048) 6443 (1913) 6427 (1828) 6397 (1842) 6396 (1856) 6250 (1854) 6405 (1886)
Prevalent conditions (%)† 16.2 14.9 14.8 14.9 17.1 16.8 15.2
ARC as defined by the International Agency for Cancer Research (breast cancer C50; colorectal cancer C18–C20; UADT (including cancer of the mouth, C01 -C15, larynx, C32, and excluding
salivary gland, C08), other cancers (all cancer mortality excluding ARC mortality)).
†Hypertension, stroke, heart attack, cancer before enrolment.

















and were better educated compared with women in other
alcohol consumption categories (table 1).
Abstainers at both baseline and follow-up had higher
BMI and lower education and were less physically active
(table 2). The proportion of those who quit both
smoking and drinking (from ≥5 g/day to never) was
1.3% of those who reduced alcohol consumption.
Alcohol intake (time-varying) and mortality
Compared with light drinkers (0.1–1.5 g/day), a statis-
tical null association with overall mortality was observed
for all categories of alcohol consumption with the excep-
tion of never drinkers. The HR comparing never with
light drinkers was 1.46 (95% CI 1.22 to 1.74) in the
smoking-adjusted model, but was reduced to HR=1.22
(95% CI 1.02 to 1.46) in the fully adjusted model
(table 3). The results were similar when women with
prevalent conditions were excluded and among never-
smokers only, with the exception that abstainers did not
experience a statistically significantly higher risk when
compared with light drinkers (data not shown).
We observed a statistically significant inverse trend
between alcohol consumption and both CVD and IHD
mortality (p value for trend=0.04 and 0.02, respectively).
Compared with light drinkers (0.1–1.5 g/day), none of
the categories of consumption reached a statistically sig-
nificant level for CVD mortality. Alcohol consumption
above 10 g/day was associated with a reduction of IHD
mortality. Overall and cause-specific mortality was similar
to the complete-case analysis (see online supplementary
table S1). Overall mortality was similar for women
enrolled in the cohort at age <40 and those enrolled
after ≥40, and also between women who exited from the
cohort at age <60 and those who exited at ≥60 years of
age (see online supplementary table S2).
Change in alcohol consumption and mortality
On the basis of a reduced number of deaths, alcohol
abstinence at 1991/1992 and follow-up in 2004, and
those who declared that they had stopped had an
increased overall mortality risk when compared with
women who maintained a low (<5 g/day) alcohol con-
sumption (table 4).
None of the interactions tested between alcohol intake
and age smoking status, BMI and physical activity level
were statistically significant in any of the outcomes
investigated.
DISCUSSION
Using the WLH cohort of young and light alcohol drink-
ing women, we observed a null association between all
levels of alcohol consumption and overall and cause-
specific mortality while alcohol abstainers appeared at
greater risk of overall mortality compared with light con-
sumers. We observed a consistent negative association
with cardiovascular and ischaemic heart disease morta-
lity. The results were similar when women with prevalent
conditions at cohort entry were excluded. Compared
with maintaining a low alcohol consumption, abstinence
and stop drinking between baseline (1991/1992) and
follow-up (2003/2004) were associated with an increased
overall mortality risk.
Study strengths included the prospective design,
detailed updated assessment of alcohol consumption
(reducing the within-person variation) and virtually
complete long-term follow-up. We used repeated mea-
surements of alcohol consumption, smoking and BMI in
order to take into account changes in these variables
over time and to attenuate the risk of measurement
errors. Measurements errors such as change in the
serving size may have occurred between baseline and
follow-up, partly explaining the increase in alcohol con-
sumption that we observed during this period. However,
they would most likely lead to a non-differential bias and
a potential underestimation of the true effect.
Analyses excluding participants with morbid condition
at cohort entry, and a small proportion of women who
quit both smoking and alcohol drinking between base-
line and follow-up suggest that reverse causality is
unlikely to have driven our results. Main limitations
included the small number of cases for specific causes
of death, especially among women drinking ≥15 g/day.
Other limitations were the self-reported alcohol con-
sumption and that we had no information on excessive
alcohol consumption in the WLH cohort. However, in
Sweden, until 2004 occasional consumption of large
amounts of alcohol was more often related to the behav-
iour of younger men, rather than middle-aged women.22
Following the International Agency for Cancer Research
(IARC) and the World Cancer Research Fund (WCRF)/
American Institute for Cancer Research (AICR) sugges-
tions,1 23 we chose not to separately study the effects of
different alcohol beverages.
Compared with other similar studies, our cohort com-
prised younger women who drank smaller quantities of
alcohol,4 24 which has not been sufficiently described
earlier. Our findings are in agreement with two recent
multicentre prospective studies from the European
Prospective Investigation into Cancer and Nutrition
(EPIC), which found that overall mortality did not differ
between light drinkers (0.1–4.9 g/day or ≤1 g/day) and
those who consumed up to 30 g/day of alcohol.3 4 We
found a similar increased risk of overall mortality among
abstainers (HR=1.22) as the above-referenced EPIC
studies (HR=1.26 and HR=1.19, respectively). In con-
trast, when comparing different amounts of alcohol
intake to abstinence, two meta-analyses found a J-shaped
dose–response relationship between alcohol and all-
cause mortality. Consumption of up to 2 drinks per day
(equivalent to 20–25 g/day of alcohol) was inversely
associated with total mortality.5 6 The protective effect
observed in some epidemiological prospective studies
may be explained by the choice of the reference group.9
In order to minimise the reverse causality problem, the
reference group should control for the so-called ‘sick
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Table 2 Women’s Lifestyle and Health cohort characteristics by change in alcohol consumption between baseline (1991) and follow-up (2004)























Mean (SD) baseline alcohol consumption*
(g/day)
1.8 (3.5) – – 1.7 (1.3) 9.3 (5.4) 2.6 (1.3) 7.9 (6.0) 4.8 (6.8)
Baseline abstainers (%) – 60 37 – – – – 3
Mean (SD) follow-up alcohol consumption*
(g/day)
– 4.0 (10.8) – 2.4 (1.5) 14.3 (14.2) 10.2 (15.4) 3.3 (1.2) –
Follow-up abstainers (%) 51.5 48.5 – – – – –
Prevalent conditions at baseline (%) 5.6 8.4 5.4 29.3 19.9 23.1 4.1 3.9
Mean (SD) age at baseline (years) 41.3 (5.7) 39.4 (5.8) 41.4 (5.9) 40.4 (5.8) 40.9 (5.6) 39.5 (5.6) 41.0 (5.7) 41.4 (5.9)
Smoking status at baseline (%)
Never 51.9 43.7 63.0 46.2 29.5 39.0 34.2 35.7
Former 27.6 34.4 21.8 35.2 44.1 40.3 40.0 38.0
Current 20.5 21.9 15.2 18.6 26.4 20.8 25.8 26.3
Smoking status at follow-up (%)
Never 51.0 42.1 61.8 45.1 28.6 37.8 33.4 –
Former 27.7 33.3 21.5 34.3 44.1 40.5 39.0 –
Current 21.3 24.6 16.7 20.6 27.3 21.7 27.6 –
Mean (SD) baseline educational attainment
(years)
11.5 (3.1) 11.4 (2.9) 11.3 (3.2) 11.9 (2.9) 12.8 (3.1) 12.4 (2.8) 12.4 (3.0) 12.4 (3.7)
Mean (SD) physical activity score
(5 categories)
3.0 (0.9) 3.0 (0.9) 3.9 (0.9) 3.1 (0.9) 3.2 (0.9) 3.2 (0.9) 3.1 (0.9) 2.9 (1.6)
Mean (SD) BMI (kg/m2) at baseline 24.3 (4.5) 23.9 (4.1) 24.5 (4.5) 23.7 (3.9) 23.1 (3.3) 23.1 (3.3) 23.4 (3.5) 23.7 (4.1)
Mean (SD) BMI (kg/m2) at follow-up 26.3 (5.2) 26.0 (4.8) 26.5 (5.3) 25.7 (4.5) 24.9 (3.8) 25.1 (4.0) 25.3 (4.7) –
All death (n) 100 132 121 411 283 260 82 711
ARC mortality (n) 21 25 18 80 66 53 14 153
Other cancers mortality (n) 39 47 52 184 119 122 36 262
CVD mortality (n) 9 20 9 30 22 21 8 58
IHD mortality (n) 7 14 14 25 9 8 9 42
External causes of deaths (n) 3 3 6 19 17 17 7 111
Other deaths (n) 23 24 24 80 55 43 10 93
ARC as defined by the International Agency for Cancer Research (breast cancer C50; colorectal cancer C18–C20; UADT (including cancer of the mouth, C01 -C15, larynx, C32, and excluding
salivary gland, C08). (all cancer mortality excluding ARC mortality)).
*Among alcohol consumers at baseline.

















quitters’, especially in European cohorts where the phe-
nomenon of sick quitting is prevalent.25 26
We observed a higher overall mortality in abstainers
and women who stop drinking. However, alcohol drin-
kers may differ from abstainers in unmeasured ways that
influence mortality,27 and so uncontrolled confounding
cannot be ruled out in our study. The risk of death of
women who abstained decreased when finer socio-
economic characteristics such as income, employment
status, ethnicity and social isolation were controlled
for.28 We observed a decrease in abstainer’s risk of
overall mortality from the smoking-adjusted model to
the fully adjusted model. Our results were similar when
women with prevalent conditions at cohort entry were
excluded; nevertheless, residual confounding for ‘sick
quitters’ in the abstainers group could have contribu-
ted to the increased risk association for abstainers with
all-cause mortality. Alcohol consumption was self-
reported in our study and misclassification of the
amount of alcohol intake, as well as lack of accuracy in
reporting prevalent morbid conditions at baseline in
the group of abstainers, could explain the excess risks
observed.
For light-to-moderate alcohol consumption (up to
30 g/day), our results were similar to the EPIC study
conducted by Ferrari et al,3 which showed no association
in any of the cause-specific mortalities studied (CVD,
ARC, external causes of deaths) compared with 0.1–
4.9 g/day of alcohol intake. In contrast with this EPIC
study, we did not observe a statistically increased risk in
any of the cause-specific mortalities studied among
abstainers. Like previous studies,7 another EPIC study,4
showed a lower effect on CVD mortality (excluding IHD
mortality) when light-to-moderate (up to 30 g/day)
intake was compared with light (≤1 g/day) alcohol
intake. The two studies from EPIC had only one meas-
urement of alcohol consumption and their reference
group; ‘light’ alcohol consumption was different (0.1–
4.9 g/day and ≤1 g/day). Cardiovascular benefits of
alcohol have not been confirmed by a recent Mendelian
randomisation project,29 and were limited to older
women ≥65 years in pooled analyses of all-cause mortal-
ity associated with alcohol consumption.30 In addition,
even if low-dose alcohol consumption reduces CVD and
IHD mortality, the increased incidence of cancer,31 32
traffic accidents and risk for alcohol dependence2
weaken any possible benefits. The biological explanation
most often proposed for the potential ‘cardioprotective’
effect of alcohol is an increase in high-density lipopro-
tein cholesterol.33
Most cohort studies only have information on alcohol
consumption at cohort entry, but alcohol consumption
is likely to vary over time.34 35 In our prospective cohort
study, we observed a considerable increase in alcohol
consumption between 1991/1992 and 2004. In Sweden,
among both men and women, over a similar period
from 1990 to 2003, annual consumption based on sales
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In women, few studies have investigated alcohol intake
over time and mortality.36–39 Continuous abstinence over
time was the reference group in three of four of the pre-
viously cited studies. In the study of Lazarus et al,38
where the reference group was light-to-moderate alcohol
consumption, similar to this study, none of the different
groups of change over time was associated with risk of
death. In the study conducted by Fillmore et al,36 com-
pared with continuous abstinence, only women who
maintained a former drinking status were associated
with an increased risk of overall mortality with a relative
risk of 1.7 (95% CI 1.2 to 2.4). Both in men and
women, starting, stopping and continuously abstaining
have been associated with declining health perception
in comparison to those who continued to drink.40
Under the missing-at-random assumption, we imputed
missing information at baseline and follow-up. We intro-
duced a large range of variables into the imputation
models to better predict incomplete or missing data.41
However, we cannot exclude that at least some of the infor-
mation is still missing-not-at-random in our data. However,
results from imputed data were similar to the complete
case analyses. To the best of our knowledge, this is the first
study examining the effect of alcohol consumption on the
risk of overall and cause-specific mortality which used
repeated information on alcohol consumption and com-
bined this method with multiple imputation.
CONCLUSION
In conclusion, in a cohort of young women, light
alcohol consumption was protective for cardiovascular
and ischaemic heart disease mortality but not for cancer
and overall mortality.
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